Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Dexamethasone + Etoposide in HLH
NCT05546060Phase 1Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of venetoclax in hemophagocytic lymphohistiocytosis (HLH), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
venetoclax
03
Conditions
hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT05546060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05546060.